Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Julia O. Davydova"'
Autor:
Nataliya Petinati, Nina J. Drize, Kseniya A. Nikiforova, Georgiy Arapidi, Elena N. Parovichnikova, Larisa A. Kuzmina, Valeriy G. Savchenko, Julia O. Davydova, Alexey Bigildeev
Publikováno v:
Blood. 138:1101-1101
Introduction Despite the large number of clinical studies on the use of multipotent mesenchymal stromal cells (MSCs) for the treatment and prevention of graft-versus-host disease (GVHD), the mechanism of their action in the organism is not well under
Autor:
Z V Konova, Valeriy G. Savchenko, V A Vasilyeva, Irina V. Galtseva, Hunan Julhakyan, Mikhail Drokov, Julia O. Davydova, Elena N. Parovichnikova, Sergey M. Kulikov, Larisa A. Kuzmina, Nikolay M. Kapranov
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S296
Context: The independent influence of pre-transplant MRD status on the results of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is now being widely reported. The genetic and immunophenotypic diversity of AML is a problem for monitori
Autor:
Ekaterina D. Mikhalcova, Mikhail Drokov, V A Vasilyeva, Larisa A. Kuzmina, Nikolay M. Kapranov, Julia O. Davydova, Olga Koroleva, Valery G. Savchenko, Elena N. Parovichnikova, Irina V. Galtseva, D S Dubnyak, N N Popova
Publikováno v:
Leukemia Research. 54:25-29
Acute Graft-versus-host-disease (aGVHD), the major complication and one of the main causes of poor outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Nowadays there are no widely accepted cell, plasma or another biomarker tha
Autor:
Ekaterina D. Mikhalcova, N N Popova, Nikolay M. Kapranov, Olga Koroleva, Alexander Vdovin, V N Dvirnyk, Julia O. Davydova, V A Vasilyeva, Larisa A. Kuzmina, Mikhail Drokov, Valery G. Savchenko, T V Gaponova, Irina V. Galtseva, D S Dubnyak, Elena N. Parovichnikova, Olga N. Baiteriyakova, Grigory A. Efimov
Publikováno v:
Cellular Therapy and Transplantation. 5:26-29
Autor:
V A Vasilyeva, Ekaterina D. Mikhalcova, Mikhail Drokov, Irina V. Galtseva, Nikolay M. Kapranov, D S Dubnyak, Valery G. Savchenko, Olga Koroleva, Larisa A. Kuzmina, Elena N. Parovichnikova, N N Popova, Julia O. Davydova
Publikováno v:
Cellular Therapy and Transplantation. 5:22-25
Autor:
Anna Dmitrova, Mikhail Drokov, V A Vasilyeva, Olga S. Starikova, Maria Dovidenko, Valeriy G. Savchenko, Nikolay M. Kapranov, Ulyana V. Maslikova, Ekaterina Mikhaltsova, Z V Konova, N N Popova, Julia O. Davydova, Olga Koroleva, Elena N. Parovichnikova, Irina V. Galtseva, Larisa A. Kuzmina, Hunan Julhakyan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S187
Context One of the main causes of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute leukemia (AL) patients is the disease relapse. Minimal residual disease (MRD) detected by multiparameter flow cytometry
Autor:
Vera V. Troitskaya, Zalina T. Fidarova, Hunan Julhakyan, Anastasia V. Abramova, Nikolay M. Kapranov, Anton V. Luchkin, Irina V. Galtseva, Elena N. Parovichnikova, Julia O. Davydova, Valeriy G. Savchenko, Elena Mikhailova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S342-S343
Autor:
Nikolay M. Kapranov, Maria V. Bakshinskayte, Julia O. Davydova, Nina Drize, Elena N. Parovichnikova, Valeriy G. Savchenko, Nataliya Petinati, Irina V. Galtseva, Larisa A. Kuzmina
Publikováno v:
Cellular Therapy and Transplantation. 5:39-41
Autor:
Maria Grishunina, Sergei M. Kulikov, Ksenija I. Zarubina, Elena E. Zinina, Elena Borisenkova, Vera V. Troitskaya, Elena Fokina, K D Kaplanov, Valery G. Savchenko, Pervin Zeinalova, Olga A. Gavrilina, Irina V. Galtseva, V A Lapin, Galina Baskhaeva, Sergey N. Bondarenko, Tatiana N. Obukhova, Julia O. Davydova, Elena N. Parovichnikova, Julia Chabaeva, Tatiana Konstantinova, Andrey N. Sokolov, Olga Samoilova
Publikováno v:
Blood. 134:5072-5072
Introduction. MRD-tailored therapy based on pediatric-inspired intensification is a back-bone of the majority of the European study groups in adult ALL. Taking in consideration the major pitfalls of the first Russian acute lymphoblastic leukemia stud
Autor:
Mikhail Yu. Drokov, Ulyana V. Maslikova, N N Popova, Z V Konova, Tatiana I. Lobanova, Irina V. Galtseva, Ekaterina Mikhaltsova, V A Vasilyeva, Olga Koroleva, Elena N. Parovichnikova, Larisa A. Kuzmina, Julia O. Davydova, Olga S. Starikova, Maria V. Nareyko, Valeriy G. Savchenko, Ekaterina I. Usikova, Nikolay M. Kapranov, Anna Dmitrova
Publikováno v:
Blood. 134:4562-4562
Introduction. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) could be curative for acute myeloid leukemia (AML) patients. However, the disease relapse after allo-HSCT lead to poor outcomes almost in all cases. Minimal residual disease